Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Role of Immune Checkpoint Inhibitors in the Management of Non-Small Cell Lung Cancer

A CME Program During The 2017 IASLC Chicago Multidisciplinary Symposium in Thoracic Oncology

Data + Perspectives: Clinical Investigators Explore the Emerging Role of PARP Inhibition in the Management of Breast Cancer

Addressing Current Questions and Controversies in the Management of Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Waldenström Macroglobulinemia and Amyloidosis

A 2-Part Friday Satellite Symposia Series Preceding the 59th ASH Annual Meeting

The 15th Annual Winter Lung Cancer Conference